LINC02423

Across TCGA pan-cancer cohorts, LINC02423 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated LINC02423 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher LINC02423 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02423 expression acts as an unfavorable survival marker.

UCEC, STAD, and THYM are the cancer types where LINC02423 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	II,III,IV	0.198	0.768	.002	72	view →
STAD	OS	Tertile	II,III,IV	0.288	0.729	<.001	45	view →
THYM	DFS	Tertile	II,III,IV	0.172	0.747	.005	36	view →
LUAD	OS	Tertile	All	0.235	0.697	.010	36	view →
READ	DFS	Tertile	All	0.179	0.701	.022	27	view →
BLCA	DFS	Tertile	All	0.174	0.625	.023	18	view →
KIRC	DFS	Tertile	IV	0.204	0.637	.034	18	view →
GBM	OS	Tertile	All	0.153	0.421	.003	18	view →
SARC	DFS	Tertile	All	0.118	0.591	.034	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

LINC02423–UCEC (OS)

Open the UCEC breakdown →